Also known as: small molecule drugs, small-molecule drugs, Small-molecule drugs
China's lab monkey prices nearly doubled to 178,000 yuan as drug development demand surges. The shortage is delaying preclinical studies, and the annual shortfall could reach 20,000 monkeys.
Junshi Biosciences reported total revenue of approximately RMB2,498 million in 2025, a 28% increase year-over-year, driven by toripalimab sales growth. Absci Corporation announced it will report fourth quarter and full year 2025 financial results on March 24, 2026.
The blood-brain barrier continues to block most treatments for glioblastoma and central nervous system diseases, with only 0.01% of biologic drugs reaching the brain. New intellectual property coverage and synthetic methods aim to address delivery challenges.
